ADM, a global leader in innovative solutions from nature, announced that Fibersol®, a premier line of soluble prebiotic fibers, has received approval from the Therapeutic Goods Administration (TGA), part of the Australian Department of Health, for use as an active ingredient in biologicals, listed medicines, and prescription medicines. The approval expands Fibersol®’s role beyond conventional food and beverage applications into dietary supplements and other regulated health product categories.
“Securing TGA approval for Fibersol® marks a significant development for ADM,” said Helen Hu, president of health & wellness APAC at ADM. “It allows our customers to highlight Fibersol®’s clinically supported health benefits on packaging, providing clear value in a category where consumer trust is essential. In today’s dynamic health and wellness market, regulatory approvals are more than a requirement; they are a mark of credibility. With this approval, ADM continues to deliver science-backed solutions that give brands a competitive edge and consumers greater confidence in their choices.”
Backed by more than 100 scientific publications, Fibersol® has been extensively researched, demonstrating its potential across a wide range of health indications. Clinically documented results show that Fibersol®:
- Promotes the growth of beneficial gut bacteria1,2
- Supports a healthy gut microbiota and overall digestive health1,2
- Nourishes intestinal flora and maintains a balanced intestinal environment2
- May delay hunger and support normal production of GLP-1 and peptide yy3
- Consumption of Fibersol-2™ is associated with a reduction in the uptake of sugars from dietary carbohydrates and in the absorption of dietary triglycerides4,5
In addition to its clinically supported benefits, Fibersol® is well-tolerated and versatile6, with stability observed under heat, acid, shear, and freeze/thaw conditions. Its neutral taste profile makes it easy to incorporate across foods, beverages, and dietary supplements, enabling brands to deliver enjoyable, gut- friendly products without compromising on taste or texture.
The prebiotics market in Australia is projected to grow at a CAGR of 17.6 % between 2024 and 20307, driven by rising consumer focus on digestive health. Nearly 40 % of Australian consumers have taken steps to improve their digestive health in the past year, of which more than one-third (39 %) are choosing supplements and vitamins to support this goal8, highlighting a shift toward targeted, science-backed solutions.
This growing interest in digestive health aligns with the expanding role of prebiotic fibers in supplements and functional products. ADM’s latest approval adds to its portfolio of TGA-recognised ingredients, following DE111™ in 2024, and underscores Fibersol®’s strong clinical foundation.
1Fahey, GC. J. Nutr., 130, 1267-1273
2Burns A. (2018). Nutrition Research, 60, 33-42
3Ye, Z. (2015). Nutritional Research, 35, 393-400
4Yuasa, M. et al. (2004). Jpn Innov Food Ingred Res, 7:83-93
5Tanaka, T. et al. (2011), Jpn Pharmocol Ther., 339: 813-821 Randomized double-blind crossover study (73 subjects) on carbonated beverage with 5g resistant maltodextrin taken with high fat meal (42 g fat) showed significantly lower postprandial serum triglycerides compared to placebo
6Kishimoto, Y., et al. (2013) J. Nutr. Sci. Vitaminol (Tokyo) 59(4):352-7
7Grand View Research, Australia Prebiotics Market Size & Outlook, 2023-2030
8ADM Outside Voice Lifestyle Survey 2025
Commitment to reach net-zero greenhouse gas emissions by 2050
SIG received approval for its group-wide Net-Zero science-based target from the Science Based Targets initiative (SBTi). The company has committed to reach net-zero greenhouse gas (GHG) emissions across its value chain by 2050 – the most ambitious commitment available through the SBTi process. Of the 2,000+ companies globally with a public net-zero pledge, SIG is among the first 325 companies to have its target validated by the SBTi.
SIG has set a new series of near and long-term science-based emissions reduction targets with the SBTi, committing to reach net-zero – the point at which a balance is achieved between emissions produced and emissions taken from the atmosphere – by 2050. These targets are significantly more ambitious than the company’s previous GHG reduction targets, approved by the SBTi in 2018 and 2020. The move sees SIG look beyond its own operations and commit to the decarbonization of its full value chain in line with climate science.
SIG’s new near-term 2030 commitments (using 2020 as the baseline year) include:
- 42 % absolute reduction of scope 1 and 2 GHG emissions
- 100 % renewable electricity through 2030
- 51.6 % reduction of scope 3 GHG emissions per liter packed
SIG’s new long-term 2050 targets include:
- 90 % absolute reduction of scope 1 and 2 GHG emissions
- 97 % reduction of scope 3 GHG emissions per liter packed
Samuel Sigrist, CEO at SIG: “The approval of our Net-Zero pathway by the SBTi is a milestone achievement that showcases our dedication to decarbonizing our operations and value chain. Our new targets are considerably bolder than our previous GHG reduction targets and have been well received by our stakeholders. Decarbonizing our business will not be an easy task, but we’re excited to speed up our journey to net-zero as one of the first 325 companies that have received SBTi approval.”
Meeting the Paris Agreement goals and limiting global warming to 1.5 °C requires net-zero carbon emissions globally by 2050. The SBTi’s rigid approval process helps ensure that SIG is using a robust, clear, and scientific framework to contribute to global efforts to mitigate climate change impacts.
The main ways SIG is reducing its operational emissions (scope 1 and 2) are its 100 % renewable electricity commitment and outstanding on-site solar installation program, as well as exploring low carbon energy sources to lower direct emissions.
SIG’s products play a major role in reducing emissions across the value chain (scope 3), due to the amount and types of raw materials used. Going forward, the company’s priorities are to use less aluminum foil in its aseptic carton packs, work with suppliers to reduce emissions across the supply chain, further improve energy efficiency with new filling lines, and increase collection and recycling of used packaging.
Tate & Lyle PLC, a leading global provider of food and beverage solutions and ingredients, is delighted to announce that its greenhouse gas emission reduction targets for 2030 have been approved by the Science Based Targets initiative (SBTi) as consistent with levels required to meet the climate action goals of the Paris Agreement.
Announced in May 2020, Tate & Lyle’s commitment to a 30 % absolute reduction in Scope 1 and Scope 2 greenhouse gas emissions by 2030 is in line with the Paris Agreement’s central aim to keep a global temperature rise this century well below 2°C. The company’s commitment to reduce emissions from the value chain (Scope 3) by 15 % over the same period meets the SBTi’s criteria for ambitious value chain goals.
Tate & Lyle is one of only around 65 food and beverage operators globally to have its environmental commitments approved by SBTi, a collaboration between CDP, the United Nations Global Compact, World Resources Institute, and the World Wide Fund for Nature.
